Question 1

What is Amporin Pharmaceuticals AG?

Accepted Answer

Amporin Pharmaceuticals AG is a Entity.

Question 2

How often does Amporin Pharmaceuticals AG appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Amporin Pharmaceuticals AG first tracked by Ergen?

Accepted Answer

First tracked on Apr 19, 2026.

Question 4

When was Amporin Pharmaceuticals AG last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Amporin Pharmaceuticals AG's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Amporin Pharmaceuticals AG in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Amporin Pharmaceuticals AG?

Accepted Answer

SynSmart, Amporin Collaborate on Therapeutics (Apr 19, 2026, 7 articles).

Question 8

How did the "SynSmart, Amporin Collaborate on Therapeutics" event impact Amporin Pharmaceuticals AG?

Accepted Answer

Amporin Pharmaceuticals AG collaborated with SynSmart Rasayan Research Private Limited to accelerate the development of disease-modifying treatments for degenerative diseases, validating its unique asset platform.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.